<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.0-a.7'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//biosimilarsrr.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://biosimilarsrr.com/2026/07/02/biosimilar-bytes-golimumab-patent-litigation-positive-keytruda-biosimilar-trial-results/</loc>
  <lastmod>2026-07-02T17:26:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biosimilars Review &amp; Report</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Biosimilar Bytes: Golimumab Patent Litigation, Positive Keytruda Biosimilar Trial Results</news:title>
   <news:publication_date>2026-07-02T17:25:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://biosimilarsrr.com/2026/07/01/samsung-bioepis-reboots-byooviz-marketing-with-harrow-at-the-helm/</loc>
  <lastmod>2026-07-01T17:28:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biosimilars Review &amp; Report</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Samsung Bioepis Reboots Byooviz Marketing With Harrow at the Helm</news:title>
   <news:publication_date>2026-07-01T16:07:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
